In This Article:
Halma has acquired France-based electrosurgical instrument developer Lamidey Noury Medical for €50m ($52.6m).
This strategic move is set to enhance Halma's healthcare offerings by integrating advanced medical devices that are crucial for minimally invasive surgeries.
With this acquisition, Lamidey Noury will operate as a standalone company within Halma's healthcare sector, continuing under its current management team.
This underscores Halma's commitment to advancing healthcare through innovative solutions and strategic growth.
Lamidey Noury's electrosurgical instruments are claimed to be widely adopted by healthcare professionals worldwide.
They are used during surgeries at the time of cutting tissue and controlling bleeding, which subsequently improves patient outcomes and operational efficiencies.
The acquisition is timely as the demand for specialised medical care increases, driven by an ageing population and a rise in urological and gynaecological diseases among younger individuals.
Halma Group chief executive Marc Ronchetti said: “I am excited to welcome Lamidey Noury to Halma. This acquisition aligns perfectly with our mission of improving patient outcomes.
“Lamidey Noury's innovative solutions will enhance our portfolio of minimally invasive surgical product capabilities. With Halma's global reach and resources, we look forward to supporting its development as it continues to scale its business globally.”
The adoption of minimally invasive procedures is increasing, due to their benefits of shorter recovery times and reduced risks.
Electrosurgical instruments are crucial for these procedures, offering precision and control that lead to safer surgeries.
Lamidey Noury Medical president Guillaume Noury said: "Joining Halma is an exciting opportunity for us. Leveraging Halma's expertise, resources, and global reach will accelerate our growth and innovation.
“We are confident in our ability to continue delivering high-quality surgical tools to our customers worldwide while providing new opportunities for our employees and stakeholders. Together, we will continue improving patient outcomes and driving excellence in healthcare.”
In March, the company acquired Rovers Medical Devices, a company specialising in sample collection devices for cervical cancer prevention and diagnosis, for €85m.
"Halma acquires Lamidey Noury Medical to bolster healthcare sector offerings" was originally created and published by Medical Device Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.